IL-1β and glycemia levels are inversely proportional in early period of allo- and xeno-transplantation of islets of Langerhans


Creative Commons License

Gürol A. O. , Süzergöz F., Küçüksezer U. C. , Çevik A. , Deniz G.

Metabolic and Functional Research on Diabetes (Online) , cilt.3, ss.15-19, 2010 (Diğer Kurumların Hakemli Dergileri)

  • Cilt numarası: 3
  • Basım Tarihi: 2010
  • Dergi Adı: Metabolic and Functional Research on Diabetes (Online)
  • Sayfa Sayıları: ss.15-19

Özet

The aim of diabetes treatment must be to obtain normal glucose metabolism and prevent or reverse the late complications of the disease. Interest in islet transplantation for type 1 diabetes treatment is increasing, but immune mediated graft rejection is still a major concern at the time of transplantation. Previous findings have shown that interleukin 1-beta (IL-1β) is important in initiating β-cell dysfunction and cellular damage. In this study, IL-1β release and its relationship to glycemia levels
following transplantation of allo- or xenogeneic islets of Langerhans into the liver of healthy and diabetic rats were investigated. IL-1β and glycemia levels were found to be inversely related in early post-transplant period. Monitoring cytokine profiles of
recipients, especially in peri-transplant period, seems to be a promising measure of graft functioning.